To include your compound in the COVID-19 Resource Center, submit it here.

Aegerion raises $50.4 million

Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) raised $50.4 million through the sale of

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE